Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases

Eur Respir J. 2017 Jul 5;50(1):1700648. doi: 10.1183/13993003.00648-2017. Print 2017 Jul.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aminosalicylic Acid / administration & dosage
  • Antitubercular Agents / therapeutic use*
  • Carbapenems / administration & dosage
  • Clofazimine / administration & dosage
  • Communicable Disease Control / standards*
  • Diarylquinolines / administration & dosage
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Humans
  • Infectious Disease Medicine / standards*
  • Isoniazid / administration & dosage
  • Linezolid / administration & dosage
  • Mycobacterium tuberculosis
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • World Health Organization

Substances

  • Antitubercular Agents
  • Carbapenems
  • Diarylquinolines
  • Aminosalicylic Acid
  • bedaquiline
  • Clofazimine
  • Linezolid
  • Isoniazid